Koerner, J., Horvath, D., Herrmann, V. L., MacKerracher, A., Gander, B., Yagita, H., . . . Groettrup, M. (2021). PLGA-particle vaccine carrying TLR3/RIG-I ligand Riboxxim synergizes with immune checkpoint blockade for effective anti-cancer immunotherapy. Nature Portfolio.
Cita Chicago Style (17a ed.)Koerner, Julia, Dennis Horvath, Valerie L. Herrmann, Anna MacKerracher, Bruno Gander, Hideo Yagita, Jacques Rohayem, y Marcus Groettrup. PLGA-particle Vaccine Carrying TLR3/RIG-I Ligand Riboxxim Synergizes with Immune Checkpoint Blockade for Effective Anti-cancer Immunotherapy. Nature Portfolio, 2021.
Cita MLA (8a ed.)Koerner, Julia, et al. PLGA-particle Vaccine Carrying TLR3/RIG-I Ligand Riboxxim Synergizes with Immune Checkpoint Blockade for Effective Anti-cancer Immunotherapy. Nature Portfolio, 2021.